Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
41.15
+0.95 (2.36%)
Aug 13, 2025, 4:00 PM - Market closed

AAPG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
3,9221,8129958519321,096
Upgrade
Market Cap Growth
82.10%82.10%16.89%-8.64%-15.02%39.78%
Upgrade
Enterprise Value
3,9781,8961,0098307981,045
Upgrade
PS Ratio
29.1913.4831.7827.99212.05574.86
Upgrade
PB Ratio
104.4248.2399.8714.364.798.45
Upgrade
P/TBV Ratio
175.1080.87-19.595.159.47
Upgrade
EV/Sales Ratio
29.6114.1132.2427.31181.70548.17
Upgrade
Debt / Equity Ratio
6.096.0925.424.390.880.63
Upgrade
Asset Turnover
0.380.380.080.070.010.01
Upgrade
Inventory Turnover
2.562.562.383.29--
Upgrade
Quick Ratio
1.171.171.351.785.053.77
Upgrade
Current Ratio
1.261.261.441.865.223.91
Upgrade
Return on Equity (ROE)
-235.32%-235.32%-386.28%-107.45%-75.18%-78.02%
Upgrade
Return on Assets (ROA)
-9.25%-9.25%-20.92%-19.14%-24.97%-29.14%
Upgrade
Return on Capital (ROIC)
-12.43%-12.43%-27.41%-24.43%-31.57%-36.13%
Upgrade
Earnings Yield
-1.42%-3.07%-13.12%-15.04%-13.22%-9.47%
Upgrade
FCF Yield
-0.48%-1.03%-10.95%-14.60%-17.57%-12.02%
Upgrade
Buyback Yield / Dilution
-7.00%-7.00%-7.07%-3.56%-17.93%-84.97%
Upgrade
Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q